Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what risk assessment he has made of the implications of ending UK participation with the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) European Drug Report 2021; and on what basis the UK Government has withdrawn from participation, in the context of EU membership not being a requirement.
In line with the Withdrawal Agreement, the United Kingdom ceased to be a member of the European Monitoring Centre for Drugs and Drug Addition (EMCDDA) on 31 January 2020. As the UK is no longer a member of EMCDDA, it does not take part in the annual reporting process.
The UK continues to have strong domestic drugs monitoring and surveillance systems, augmented through our sharing of information and expertise with international partners, including the United Nations Office on Drugs and Crime and the World Health Organization.